Medical Oncology Updates in Unresectable HCC: Where Are We and Where Are We Going?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Johns Hopkins

2023 Updates in Gastrointestinal Cancers
Videos
Events

Playback speed

10 seconds

Medical Oncology Updates in Unresectable HCC: Where Are We and Where Are We Going?

By 2023 Johns Hopkins Updates in Gastrointestinal Cancers FEATURING Daneng Li

237 views

March 7, 2023

For more accreditation information, please visit https://integrityce.com/HopkinsGI2023

Comments 0

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

2023 Updates in Gastrointestinal Cancers

HCC and IO: Does Etiology Matter?

2023 Johns Hopkins Updates in Gastrointestinal Cancers

W. Jin Ho

255 views

Great Debate: Neoadjuvant vs. Adjuvant Therapy for High-Risk BTC - P…

2023 Johns Hopkins Updates in Gastrointestinal Cancers

M. Yarchoan

497 views

Great Debate: Neoadjuvant vs. Adjuvant Therapy for High-Risk BTC - P…

2023 Johns Hopkins Updates in Gastrointestinal Cancers

T. Karasic

359 views

Medical Oncology Updates in BTC

2023 Johns Hopkins Updates in Gastrointestinal Cancers

M. Baretti

242 views

The Option of Radiation Therapy for HCC

2023 Johns Hopkins Updates in Gastrointestinal Cancers

J. Meyer

269 views

Very Large Solitary HCC: Resectable Disease Should Be Resected

2023 Johns Hopkins Updates in Gastrointestinal Cancers

C. Shubert

77 views